Patent · US Active

Substituted benzimidazole and substituted benzothiazole inhibitors of transforming growth factor-β kinase and methods of use thereof

US10207998B2 · kind B2 · utility

3Cited by
2References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 29, 2017
Grant dateFeb 19, 2019
Priority date
Expiry dateSep 29, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D277/82
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides novel inhibitors of TAK1 having formula (I) and methods of using such compounds to treat various diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.